Success Story: Pain Sensory Neurobiology Research Earns NIW Approval in Just 2 Months, 17 Days
Client’s Testimonial:
"Thank you for your support."
On July 28th, 2026, we received another EB-2 NIW (National Interest Waiver) approval for a Postdoctoral Researcher in the Field of Pain Sensory Neurobiology (Approval Notice).
General Field: Pain Sensory Neurobiology
Position at the Time of Case Filing: Postdoctoral Researcher
Country of Origin: Nepal
State of Residence at the Time of Filing: Pennsylvania
Approval Notice Date: July 28th, 2026
Processing Time: 2 months, 17 days (Premium Processing Requested)
Case Summary:
Neuropathic pain affects millions of people and remains one of the most challenging conditions to treat effectively, particularly because existing therapies often provide limited relief or rely on opioids. The client's proposed endeavor focused on identifying the fundamental cellular and molecular mechanisms responsible for pathological sensory disorders and chronic pain. By combining advanced electrophysiological techniques, molecular profiling, and functional behavioral modeling, the client's research sought to uncover new therapeutic targets. This work directly supported the development of safer, non-opioid treatments for chronic pain associated with complex medical interventions, neurotoxicity, and severe inflammatory conditions.
To demonstrate that the client was well positioned to advance this nationally important endeavor, the petition documented a growing record of scholarly achievement, including:
- Ph.D. in Neuroscience
- 8 peer-reviewed journal articles
- 37 citations to published research
- At least 4 completed peer reviews
- Research funding from the National Institutes of Health (NIH)
North America Immigration Law Group (Chen Immigration Law Associates) presented evidence showing that the client's research addressed a significant public health challenge while supporting broader national priorities. The petition emphasized that an improved understanding of neuropathic pain mechanisms could accelerate the development of non-opioid therapies, reduce the health and economic burden associated with chronic pain, and advance personalized treatment strategies.
This approval demonstrates the importance of research aimed at improving the understanding and treatment of chronic pain through innovative neuroscience approaches. We are delighted that we could help present a compelling NIW petition showing how the client's expertise in pain sensory neurobiology, growing record of scientific achievement, and commitment to developing safer, non-opioid therapies support long-term benefits for public health and medical innovation in the United States.